Authors: De Placido, S Lauria, R Perrone, F Lombardi, AV Carlomagno, C Varriale, E Costanzo, R Leo, L De Laurentiis, M Bianco, AR

Citation: S. De Placido et al., Vinorelbine plus mitomycin C as second-line treatment of metastatic breastcancer: A two-stage phase 2 study, ONCOL-BASEL, 58(1), 2000, pp. 8-14

Authors: De Placido, S Carlomagno, C Ciardiello, F De Laurentiis, M Pepe, S Ruggiero, A Tortora, G Panico, L D'Antonio, A Pettinato, G Petrella, G Bianco, AR

Citation: S. De Placido et al., Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up, CLIN CANC R, 5(10), 1999, pp. 2854-2859

Authors: De Placido, S Lauria, R Carlomagno, C Perrone, F De Laurentiis, M Gallo, C Martignetti, A Bellelli, T Limite, G Petrella, G Bianco, AR

Citation: S. De Placido et al., The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer, INT J ONCOL, 15(2), 1999, pp. 339-346

Authors: Lauria, R Ferrari, E Tramontana, S Morabito, A Perrone, F Maffeo, A Fiorentino, R Casella, G Iodice, F Ricchi, P Carlomagno, C Varriale, E De Placido, G De Placido, S Bianco, AR Pignata, S

Citation: R. Lauria et al., A phase I study of paclitaxel and epirubicin, without and with filgrastim,for the treatment of platinum-resistant advanced ovarian cancer, ONCOL-BASEL, 56(4), 1999, pp. 267-273

Authors: De Placido, S Carlomagno, C De Laurentiis, M Bianco, AR

Citation: S. De Placido et al., c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients, BREAST CANC, 52(1-3), 1998, pp. 55-64